DK360287A - Sproejteklare, vandige, alkaliske injektionsoploesninger af torasemid og fremgangsmaade til fremstilling deraf - Google Patents

Sproejteklare, vandige, alkaliske injektionsoploesninger af torasemid og fremgangsmaade til fremstilling deraf

Info

Publication number
DK360287A
DK360287A DK360287A DK360287A DK360287A DK 360287 A DK360287 A DK 360287A DK 360287 A DK360287 A DK 360287A DK 360287 A DK360287 A DK 360287A DK 360287 A DK360287 A DK 360287A
Authority
DK
Denmark
Prior art keywords
torasemide
aqueous
present
solution
preparable
Prior art date
Application number
DK360287A
Other languages
English (en)
Other versions
DK360287D0 (da
DK174624B1 (da
Inventor
Fritz Demmer
Werner Gruber
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK360287D0 publication Critical patent/DK360287D0/da
Publication of DK360287A publication Critical patent/DK360287A/da
Application granted granted Critical
Publication of DK174624B1 publication Critical patent/DK174624B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ink Jet (AREA)
  • Pyridine Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK198703602A 1986-07-12 1987-07-10 Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf DK174624B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863623620 DE3623620A1 (de) 1986-07-12 1986-07-12 Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
DE3623620 1986-07-12

Publications (3)

Publication Number Publication Date
DK360287D0 DK360287D0 (da) 1987-07-10
DK360287A true DK360287A (da) 1988-01-13
DK174624B1 DK174624B1 (da) 2003-07-28

Family

ID=6305087

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703602A DK174624B1 (da) 1986-07-12 1987-07-10 Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (1) US4861786A (da)
EP (1) EP0253226B1 (da)
JP (1) JPS6323818A (da)
KR (1) KR950010158B1 (da)
AT (1) ATE53296T1 (da)
AU (1) AU578562B2 (da)
CA (1) CA1302278C (da)
DE (2) DE3623620A1 (da)
DK (1) DK174624B1 (da)
ES (1) ES2016306B3 (da)
FI (1) FI87993C (da)
GR (1) GR3000534T3 (da)
NZ (1) NZ221026A (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486530A (en) * 1991-04-27 1996-01-23 Boehringer Mannheim Gmbh Use of torasemide for the treatment of brain oedemas
DE4126984A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke
JP3028171B2 (ja) * 1993-08-31 2000-04-04 日本ピラー工業株式会社 複合ガスケット
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5763491A (en) * 1994-12-09 1998-06-09 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US6228873B1 (en) 1994-12-09 2001-05-08 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
JP2003527319A (ja) 1999-08-11 2003-09-16 テバ ファーマシューティカル インダストリーズ リミティド トルセミド多形体
AU2001247592B2 (en) 2000-03-20 2005-08-18 Teva Pharmaceutical Industries Ltd. Novel processes for preparing torsemide intermediate
AU2003205278B2 (en) * 2002-01-18 2008-08-07 Psivida Us Inc. Polymeric gel system for the controlled delivery of codrugs
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
CN100372534C (zh) * 2006-04-20 2008-03-05 南京海辰药业有限公司 托拉塞米冻干制剂及制备方法
US20100053852A1 (en) * 2008-09-02 2010-03-04 Cheng Uei Precision Industry Co., Ltd. Display Device
CN103371967A (zh) * 2012-04-17 2013-10-30 上海禾丰制药有限公司 呋塞米注射液及其制剂工艺
KR102493735B1 (ko) * 2013-04-05 2023-01-30 에스씨파마슈티칼스 인코포레이티드 퓨로세마이드의 피하 투여용 약학 제형
FR3077984B1 (fr) 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
AU2020214314A1 (en) 2019-01-31 2021-08-19 Scpharmaceuticals Inc. Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same
CN110606826B (zh) * 2019-05-23 2021-06-01 上海勋和医药科技有限公司 托拉塞米钠一水合物、其晶型及组合物
CN112168776B (zh) * 2020-10-30 2022-05-03 康普药业股份有限公司 一种低杂质高稳定的托拉塞米注射液和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE185374C (da) *
DE30681C (de) * R.W. traylor in Richmond, County of Henrico State of Virginia, V. St. A Gufsform aus Glimmer
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE2950832C2 (de) * 1979-12-18 1983-03-17 Hoechst Ag, 6000 Frankfurt Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid
DE3241765A1 (de) * 1982-11-11 1984-05-17 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Stabile zubereitungen fuer injektionszwecke enthaltend hydrochlorothiazid
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid

Also Published As

Publication number Publication date
NZ221026A (en) 1989-09-27
JPS6323818A (ja) 1988-02-01
DE3623620C2 (da) 1991-02-28
JPH055810B2 (da) 1993-01-25
KR950010158B1 (ko) 1995-09-11
FI873059A (fi) 1988-01-13
ES2016306B3 (es) 1990-11-01
AU7535587A (en) 1988-01-14
DE3623620A1 (de) 1988-01-21
KR880001294A (ko) 1988-04-22
FI87993C (fi) 1993-03-25
FI87993B (fi) 1992-12-15
ATE53296T1 (de) 1990-06-15
EP0253226B1 (de) 1990-06-06
GR3000534T3 (en) 1991-07-31
AU578562B2 (en) 1988-10-27
CA1302278C (en) 1992-06-02
DK360287D0 (da) 1987-07-10
EP0253226A1 (de) 1988-01-20
DK174624B1 (da) 2003-07-28
US4861786A (en) 1989-08-29
DE3763010D1 (de) 1990-07-12
FI873059A0 (fi) 1987-07-10

Similar Documents

Publication Publication Date Title
DK360287A (da) Sproejteklare, vandige, alkaliske injektionsoploesninger af torasemid og fremgangsmaade til fremstilling deraf
NZ334710A (en) Heterocycle derivatives which inhibit factor Xa attributed to strong anticoagulant and antithrombotic effect of compounds
PT79834A (fr) Procede de preparation de nouveaux derives de la xanthine
AR245718A1 (es) Procedimiento para preparar un compuesto de imidazo (4,5-b)-piridina
ATE62416T1 (de) Stabilisierte injektionsloesungen von piroxicam.
MA19860A1 (fr) Procede de preparation de nouveaux derives de la xanthine .
EA199600024A2 (ru) Жидкая стабильная фармацевтическая композиция, содержащая уратоксидазу и лиофилизат для ее получения
ATE65084T1 (de) Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen.
FR2380782A1 (fr) Fraction 5 de thymosine stabilisee utile comme medicament et procede pour la preparer
ES2062015T3 (es) Soluciones inyectables.
DE59108859D1 (de) 3,7-Diazabicyclo(3,3,1)-nonan-Verbindungen enthaltende Arzneimittel
ATE104149T1 (de) Dialysier- und spuelloesung zur intraperitonealen verarbreichung.
KR860002269A (ko) 비경구용 액제의 제조방법
DK69287A (da) Temazepamkomposition og fremgangsmaade til fremstilling af samme
TH6314EX (th) วิธีสำหรับการทำความบริสุทธิ์ของพอลิกลูทาเมท
KR830003491A (ko) 치환된 6-아릴-4H-s-트리아졸로-〔3,4-c〕-티에노-〔2,3-e〕-1,4-디아제핀의 제조방법
KR900000081A (ko) 트리암테렌의 약학적 액제

Legal Events

Date Code Title Description
PUP Patent expired